{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:14:00Z","timestamp":1792800840765,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Vaccinex","id":[{"id":"https:\/\/ror.org\/047jxj944","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The close interaction and interdependence of astrocytes and neurons allows for the possibility that astrocyte dysfunction contributes to and amplifies neurodegenerative pathology. Molecular pathways that trigger reactive astrocytes may represent important targets to preserve normal homeostatic maintenance and modify disease progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Semaphorin 4D (SEMA4D) expression in the context of disease-associated neuropathology was assessed in postmortem brain sections of patients with Huntington\u2019s (HD) and Alzheimer\u2019s disease (AD), as well as in mouse models of HD (zQ175) and AD (CVN; APPSwDI\/NOS2\n                      <jats:sup>\u2212\/\u2212<\/jats:sup>\n                      ) by immunohistochemistry. Effects of SEMA4D antibody blockade were assessed in purified astrocyte cultures and in the CVN mouse AD model. CVN mice were treated weekly from 26 to 38\u00a0weeks of age; thereafter mice underwent cognitive assessment and brains were collected for histopathology.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We report here that SEMA4D is upregulated in neurons during progression of neurodegenerative diseases and is a trigger of reactive astrocytes. Evidence of reactive astrocytes in close proximity to neurons expressing SEMA4D is detected in brain sections of patients and mouse models of HD and AD. We further report that SEMA4D-blockade prevents characteristic loss of GABAergic synapses and restores spatial memory and learning in CVN mice, a disease model that appears to reproduce many features of AD-like pathology including neuroinflammation. In vitro mechanistic studies demonstrate that astrocytes express cognate receptors for SEMA4D and that ligand binding triggers morphological variations, and changes in expression of key membrane receptors and enzymes characteristic of reactive astrocytes. These changes include reductions in EAAT-2 glutamate transporter and glutamine synthetase, key enzymes in neurotransmitter recycling, as well as reduced GLUT-1 glucose and MCT-4 lactate transporters, that allow astrocytes to couple energy metabolism with synaptic activity. Antibody blockade of SEMA4D prevented these changes and reversed functional deficits in glucose uptake.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, these results suggest that SEMA4D blockade may ameliorate disease pathology by preserving normal astrocyte function and reducing the negative consequences of reactive astrogliosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-022-02509-8","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T02:03:52Z","timestamp":1659751432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Semaphorin 4D is upregulated in neurons of diseased brains and triggers astrocyte reactivity"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9287-9221","authenticated-orcid":false,"given":"Elizabeth E.","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4555-0132","authenticated-orcid":false,"given":"Vikas","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Mallow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M.","family":"Gersz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Balch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9326-6606","authenticated-orcid":false,"given":"Terrence L.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4253-9165","authenticated-orcid":false,"given":"Maurice","family":"Zauderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"key":"2509_CR1","doi-asserted-by":"publisher","first-page":"11758","DOI":"10.1038\/ncomms11758","volume":"7","author":"A Benraiss","year":"2016","unstructured":"Benraiss A, Wang S, Herrlinger S, Li X, Chandler-Militello D, Mauceri J, Burm HB, Toner M, Osipovitch M, Jim XuQ, et al. Human glia can both induce and rescue aspects of disease phenotype in Huntington disease. Nat Commun. 2016;7:11758.","journal-title":"Nat Commun"},{"issue":"107\u2013122","key":"2509_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2018.11.010","volume":"24","author":"M Osipovitch","year":"2019","unstructured":"Osipovitch M, Asenjo Martinez A, Mariani JN, Cornwell A, Dhaliwal S, Zou L, Chandler-Militello D, Wang S, Li X, Benraiss SJ, et al. Human ESC-derived chimeric mouse models of Huntington\u2019s disease reveal cell-intrinsic defects in glial progenitor cell differentiation. Cell Stem Cell. 2019;24(107\u2013122): e107.","journal-title":"Cell Stem Cell"},{"key":"2509_CR3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, Bennett ML, Munch AE, Chung WS, Peterson TC, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"2509_CR4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tins.2017.05.002","volume":"40","author":"BS Khakh","year":"2017","unstructured":"Khakh BS, Beaumont V, Cachope R, Munoz-Sanjuan I, Goldman SA, Grantyn R. Unravelling and exploiting astrocyte dysfunction in Huntington\u2019s disease. Trends Neurosci. 2017;40:422\u201337.","journal-title":"Trends Neurosci"},{"key":"2509_CR5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.conb.2010.06.005","volume":"20","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Barres BA. Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr Opin Neurobiol. 2010;20:588\u201394.","journal-title":"Curr Opin Neurobiol"},{"key":"2509_CR6","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nn.4043","volume":"18","author":"BS Khakh","year":"2015","unstructured":"Khakh BS, Sofroniew MV. Diversity of astrocyte functions and phenotypes in neural circuits. Nat Neurosci. 2015;18:942\u201352.","journal-title":"Nat Neurosci"},{"key":"2509_CR7","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.cell.2008.10.029","volume":"135","author":"JP Doyle","year":"2008","unstructured":"Doyle JP, Dougherty JD, Heiman M, Schmidt EF, Stevens TR, Ma G, Bupp S, Shrestha P, Shah RD, Doughty ML, et al. Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell. 2008;135:749\u201362.","journal-title":"Cell"},{"key":"2509_CR8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1126\/science.1222381","volume":"337","author":"HH Tsai","year":"2012","unstructured":"Tsai HH, Li H, Fuentealba LC, Molofsky AV, Taveira-Marques R, Zhuang H, Tenney A, Murnen AT, Fancy SP, Merkle F, et al. Regional astrocyte allocation regulates CNS synaptogenesis and repair. Science. 2012;337:358\u201362.","journal-title":"Science"},{"key":"2509_CR9","doi-asserted-by":"publisher","first-page":"8546","DOI":"10.1126\/scitranslmed.aaw8546","volume":"11","author":"B Diaz-Castro","year":"2019","unstructured":"Diaz-Castro B, Gangwani MR, Yu X, Coppola G, Khakh BS. Astrocyte molecular signatures in Huntington\u2019s disease. Sci Transl Med. 2019;11:8546.","journal-title":"Sci Transl Med"},{"key":"2509_CR10","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20167435","volume":"14","author":"SA Ament","year":"2018","unstructured":"Ament SA, Pearl JR, Cantle JP, Bragg RM, Skene PJ, Coffey SR, Bergey DE, Wheeler VC, MacDonald ME, Baliga NS, et al. Transcriptional regulatory networks underlying gene expression changes in Huntington\u2019s disease. Mol Syst Biol. 2018;14: e7435.","journal-title":"Mol Syst Biol"},{"key":"2509_CR11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","volume":"23","author":"N Habib","year":"2020","unstructured":"Habib N, McCabe C, Medina S, Varshavsky M, Kitsberg D, Dvir-Szternfeld R, Green G, Dionne D, Nguyen L, Marshall JL, et al. Disease-associated astrocytes in Alzheimer\u2019s disease and aging. Nat Neurosci. 2020;23:701\u20136.","journal-title":"Nat Neurosci"},{"key":"2509_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nn2047","volume":"11","author":"K Yamanaka","year":"2008","unstructured":"Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci. 2008;11:251\u20133.","journal-title":"Nat Neurosci"},{"key":"2509_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00401-015-1513-1","volume":"131","author":"M Pekny","year":"2016","unstructured":"Pekny M, Pekna M, Messing A, Steinhauser C, Lee JM, Parpura V, Hol EM, Sofroniew MV, Verkhratsky A. Astrocytes: a central element in neurological diseases. Acta Neuropathol. 2016;131:323\u201345.","journal-title":"Acta Neuropathol"},{"issue":"436\u2013453","key":"2509_CR14","volume":"107","author":"L Barbar","year":"2020","unstructured":"Barbar L, Jain T, Zimmer M, Kruglikov I, Sadick JS, Wang M, Kalpana K, Rose IVL, Burstein SR, Rusielewicz T, et al. CD49f is a novel marker of functional and reactive human iPSC-derived astrocytes. Neuron. 2020;107(436\u2013453): e412.","journal-title":"Neuron"},{"key":"2509_CR15","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1152\/physrev.00041.2013","volume":"94","author":"M Pekny","year":"2014","unstructured":"Pekny M, Pekna M. Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol Rev. 2014;94:1077\u201398.","journal-title":"Physiol Rev"},{"key":"2509_CR16","doi-asserted-by":"publisher","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG, Barres BA. Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32:6391\u2013410.","journal-title":"J Neurosci"},{"key":"2509_CR17","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","volume":"24","author":"C Escartin","year":"2021","unstructured":"Escartin C, Galea E, Lakatos A, O\u2019Callaghan JP, Petzold GC, Serrano-Pozo A, Steinhauser C, Volterra A, Carmignoto G, Agarwal A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24:312\u201325.","journal-title":"Nat Neurosci"},{"key":"2509_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.freeradbiomed.2017.07.024","volume":"112","author":"W Liu","year":"2017","unstructured":"Liu W, Zhuo P, Li L, Jin H, Lin B, Zhang Y, Liang S, Wu J, Huang J, Wang Z, et al. Activation of brain glucose metabolism ameliorating cognitive impairment in APP\/PS1 transgenic mice by electroacupuncture. Free Radic Biol Med. 2017;112:174\u201390.","journal-title":"Free Radic Biol Med"},{"key":"2509_CR19","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/jnen\/nly102","volume":"77","author":"M Zhang","year":"2018","unstructured":"Zhang M, Cheng X, Dang R, Zhang W, Zhang J, Yao Z. Lactate deficit in an Alzheimer disease mouse model: the relationship with neuronal damage. J Neuropathol Exp Neurol. 2018;77:1163\u201376.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2509_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nn.2535","volume":"13","author":"PI Ortinski","year":"2010","unstructured":"Ortinski PI, Dong J, Mungenast A, Yue C, Takano H, Watson DJ, Haydon PG, Coulter DA. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci. 2010;13:584\u201391.","journal-title":"Nat Neurosci"},{"key":"2509_CR21","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.neuron.2015.03.035","volume":"86","author":"PJ Magistretti","year":"2015","unstructured":"Magistretti PJ, Allaman I. A cellular perspective on brain energy metabolism and functional imaging. Neuron. 2015;86:883\u2013901.","journal-title":"Neuron"},{"key":"2509_CR22","doi-asserted-by":"publisher","first-page":"7337","DOI":"10.1523\/JNEUROSCI.23-19-07337.2003","volume":"23","author":"A Loaiza","year":"2003","unstructured":"Loaiza A, Porras OH, Barros LF. Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy. J Neurosci. 2003;23:7337\u201342.","journal-title":"J Neurosci"},{"key":"2509_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuint.2016.03.014","volume":"98","author":"MB Robinson","year":"2016","unstructured":"Robinson MB, Jackson JG. Astroglial glutamate transporters coordinate excitatory signaling and brain energetics. Neurochem Int. 2016;98:56\u201371.","journal-title":"Neurochem Int"},{"key":"2509_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nn.4492","volume":"20","author":"ER Zimmer","year":"2017","unstructured":"Zimmer ER, Parent MJ, Souza DG, Leuzy A, Lecrux C, Kim HI, Gauthier S, Pellerin L, Hamel E, Rosa-Neto P. [(18)F]FDG PET signal is driven by astroglial glutamate transport. Nat Neurosci. 2017;20:393\u20135.","journal-title":"Nat Neurosci"},{"key":"2509_CR25","doi-asserted-by":"publisher","first-page":"34888","DOI":"10.1074\/jbc.M705467200","volume":"282","author":"JR Basile","year":"2007","unstructured":"Basile JR, Gavard J, Gutkind JS. Plexin-B1 utilizes RHOA and ROK to promote the integrin-dependent activation of AKT and ERK, and endothelial cell motility. J Biol Chem. 2007;282:34888\u201395.","journal-title":"J Biol Chem"},{"key":"2509_CR26","doi-asserted-by":"publisher","first-page":"7140","DOI":"10.1523\/JNEUROSCI.5319-03.2004","volume":"24","author":"X Liang","year":"2004","unstructured":"Liang X, Draghi NA, Resh MD. Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes. J Neurosci. 2004;24:7140\u20139.","journal-title":"J Neurosci"},{"key":"2509_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0092-8674(00)80063-X","volume":"99","author":"L Tamagnone","year":"1999","unstructured":"Tamagnone L, Artigiani S, Chen H, He Z, Ming GI, Song H, Chedotal A, Winberg ML, Goodman CS, Poo M, et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell. 1999;99:71\u201380.","journal-title":"Cell"},{"key":"2509_CR28","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s41380-018-0021-9","volume":"24","author":"HL Denis","year":"2019","unstructured":"Denis HL, Lauruol F, Cicchetti F. Are immunotherapies for Huntington\u2019s disease a realistic option? Mol Psychiatry. 2019;24:364\u201377.","journal-title":"Mol Psychiatry"},{"key":"2509_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.neuint.2009.05.013","volume":"55","author":"M Toguchi","year":"2009","unstructured":"Toguchi M, Gonzalez D, Furukawa S, Inagaki S. Involvement of Sema4D in the control of microglia activation. Neurochem Int. 2009;55:573\u201380.","journal-title":"Neurochem Int"},{"key":"2509_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00011-016-0983-5","volume":"66","author":"SP Chapoval","year":"2017","unstructured":"Chapoval SP, Vadasz Z, Chapoval AI, Toubi E. Semaphorins 4A and 4D in chronic inflammatory diseases. Inflamm Res. 2017;66:111\u20137.","journal-title":"Inflamm Res"},{"key":"2509_CR31","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1517\/14728222.2016.1139083","volume":"20","author":"M Wu","year":"2016","unstructured":"Wu M, Li J, Gao Q, Ye F. The role of Sema4D\/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseases. Expert Opin Ther Targets. 2016;20:885\u2013901.","journal-title":"Expert Opin Ther Targets"},{"key":"2509_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.nbd.2014.10.008","volume":"73","author":"ES Smith","year":"2014","unstructured":"Smith ES, Jonason AJ, Reilly C, Veeraraghavan J, Fisher T, Doherty M, Klimatcheva E, Mallow C, Cornelius C, Leonard JE, et al. SEMA4D compromises blood-brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease. Neurobiol Dis. 2014;73:254\u201368.","journal-title":"Neurobiol Dis"},{"key":"2509_CR33","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.4049\/jimmunol.0903302","volume":"184","author":"T Okuno","year":"2010","unstructured":"Okuno T, Nakatsuji Y, Moriya M, Takamatsu H, Nojima S, Takegahara N, Toyofuku T, Nakagawa Y, Kang S, Friedel RH, et al. Roles of SEMA4D-plexin-B1 interactions in the central nervous system for pathogenesis of experimental autoimmune encephalomyelitis. J Immunol. 2010;184:1499\u2013506.","journal-title":"J Immunol"},{"key":"2509_CR34","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1002\/glia.22890","volume":"63","author":"T Sawano","year":"2015","unstructured":"Sawano T, Watanabe F, Ishiguchi M, Doe N, Furuyama T, Inagaki S. Effect of Sema4D on microglial function in middle cerebral artery occlusion mice. Glia. 2015;63:2249\u201359.","journal-title":"Glia"},{"key":"2509_CR35","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.4049\/jimmunol.172.2.1246","volume":"172","author":"P Giraudon","year":"2004","unstructured":"Giraudon P, Vincent P, Vuaillat C, Verlaeten O, Cartier L, Marie-Cardine A, Mutin M, Bensussan A, Belin MF, Boumsell L. Semaphorin CD100 from activated T lymphocytes induces process extension collapse in oligodendrocytes and death of immature neural cells. J Immunol. 2004;172:1246\u201355.","journal-title":"J Immunol"},{"key":"2509_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1385\/NMM:7:3:207","volume":"7","author":"P Giraudon","year":"2005","unstructured":"Giraudon P, Vincent P, Vuaillat C. T-cells in neuronal injury and repair: semaphorins and related T-cell signals. Neuromolecular Med. 2005;7:207\u201316.","journal-title":"Neuromolecular Med"},{"key":"2509_CR37","doi-asserted-by":"publisher","first-page":"9229","DOI":"10.1523\/JNEUROSCI.23-27-09229.2003","volume":"23","author":"C Moreau-Fauvarque","year":"2003","unstructured":"Moreau-Fauvarque C, Kumanogoh A, Camand E, Jaillard C, Barbin G, Boquet I, Love C, Jones EY, Kikutani H, Lubetzki C. The transmembrane semaphorin Sema4D\/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. J Neurosci. 2003;23:9229\u201339.","journal-title":"J Neurosci"},{"key":"2509_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neuroscience.2017.03.030","volume":"351","author":"S-X Peng","year":"2017","unstructured":"Peng S-X, Yao L, Cui C. Liu C-j, Li Y-h, Wang L-f, Huang S-b, Shen Y-q: Semaphorin4D promotes axon regrowth and swimming ability during recovery following zebrafish spinal cord injury. Neuroscience. 2017;351:36\u201346.","journal-title":"Neuroscience"},{"key":"2509_CR39","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1126\/science.abf1230","volume":"372","author":"IC Clark","year":"2021","unstructured":"Clark IC, Gutierrez-Vazquez C, Wheeler MA, Li Z, Rothhammer V, Linnerbauer M, Sanmarco LM, Guo L, Blain M, Zandee SEJ, et al. Barcoded viral tracing of single-cell interactions in central nervous system inflammation. Science. 2021;372:1230.","journal-title":"Science"},{"key":"2509_CR40","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, Menon M, He L, Abdurrob F, Jiang X, et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature. 2019;570:332\u20137.","journal-title":"Nature"},{"key":"2509_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.nbd.2015.01.002","volume":"76","author":"AL Southwell","year":"2015","unstructured":"Southwell AL, Franciosi S, Villanueva EB, Xie Y, Winter LA, Veeraraghavan J, Jonason A, Felczak B, Zhang W, Kovalik V. Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease. Neurobiol Dis. 2015;76:46\u201356.","journal-title":"Neurobiol Dis"},{"key":"2509_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049838","volume":"7","author":"LB Menalled","year":"2012","unstructured":"Menalled LB, Kudwa AE, Miller S, Fitzpatrick J, Watson-Johnson J, Keating N, Ruiz M, Mushlin R, Alosio W, McConnell K, et al. Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington\u2019s disease: zQ175. PLoS ONE. 2012;7: e49838.","journal-title":"PLoS ONE"},{"key":"2509_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3389\/fncel.2013.00003","volume":"7","author":"A Karperien","year":"2013","unstructured":"Karperien A, Ahammer H, Jelinek HF. Quantitating the subtleties of microglial morphology with fractal analysis. Front Cell Neurosci. 2013;7:3.","journal-title":"Front Cell Neurosci"},{"key":"2509_CR44","first-page":"57648","volume":"136","author":"K Young","year":"2018","unstructured":"Young K, Morrison H. Quantifying microglia morphology from photomicrographs of immunohistochemistry prepared tissue using ImageJ. J Vis Exp. 2018;136:57648.","journal-title":"J Vis Exp"},{"key":"2509_CR45","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/19420862.2015.1102813","volume":"8","author":"TL Fisher","year":"2016","unstructured":"Fisher TL, Reilly CA, Winter LA, Pandina T, Jonason A, Scrivens M, Balch L, Bussler H, Torno S, Seils J, et al. Generation and preclinical characterization of an antibody specific for SEMA4D. MAbs. 2016;8:150\u201362.","journal-title":"MAbs"},{"key":"2509_CR46","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1038\/nprot.2006.275","volume":"1","author":"J Alamed","year":"2006","unstructured":"Alamed J, Wilcock DM, Diamond DM, Gordon MN, Morgan D. Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice. Nat Protoc. 2006;1:1671\u20139.","journal-title":"Nat Protoc"},{"key":"2509_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234529","volume":"15","author":"B Boulan","year":"2020","unstructured":"Boulan B, Beghin A, Ravanello C, Deloulme JC, Gory-Faure S, Andrieux A, Brocard J, Denarier E. AutoNeuriteJ: an ImageJ plugin for measurement and classification of neuritic extensions. PLoS ONE. 2020;15: e0234529.","journal-title":"PLoS ONE"},{"key":"2509_CR48","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.1523\/JNEUROSCI.0316-16.2016","volume":"36","author":"A Dvorzhak","year":"2016","unstructured":"Dvorzhak A, Vagner T, Kirmse K, Grantyn R. Functional indicators of glutamate transport in single striatal astrocytes and the influence of Kir4.1 in normal and Huntington mice. J Neurosci. 2016;36:4959\u201375.","journal-title":"J Neurosci"},{"key":"2509_CR49","doi-asserted-by":"publisher","first-page":"17513","DOI":"10.1073\/pnas.0602841103","volume":"103","author":"U Wilhelmsson","year":"2006","unstructured":"Wilhelmsson U, Bushong EA, Price DL, Smarr BL, Phung V, Terada M, Ellisman MH, Pekny M. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci USA. 2006;103:17513\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2509_CR50","first-page":"381","volume":"50","author":"D Pirici","year":"2009","unstructured":"Pirici D, Mogoanta L, Margaritescu O, Pirici I, Tudorica V, Coconu M. Fractal analysis of astrocytes in stroke and dementia. Rom J Morphol Embryol. 2009;50:381\u201390.","journal-title":"Rom J Morphol Embryol"},{"key":"2509_CR51","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9","volume":"63","author":"Z Soltys","year":"2001","unstructured":"Soltys Z, Ziaja M, Pawlinski R, Setkowicz Z, Janeczko K. Morphology of reactive microglia in the injured cerebral cortex. Fractal analysis and complementary quantitative methods. J Neurosci Res. 2001;63:90\u20137.","journal-title":"J Neurosci Res"},{"key":"2509_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ. Huntington\u2019s disease: a clinical review. Eur J Neurol. 2018;25:24\u201334.","journal-title":"Eur J Neurol"},{"key":"2509_CR53","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3233\/JAD-2008-15405","volume":"15","author":"CA Colton","year":"2008","unstructured":"Colton CA, Wilcock DM, Wink DA, Davis J, Van Nostrand WE, Vitek MP. The effects of NOS2 gene deletion on mice expressing mutated human AbetaPP. J Alzheimers Dis. 2008;15:571\u201387.","journal-title":"J Alzheimers Dis"},{"key":"2509_CR54","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/NEN.0000000000000094","volume":"73","author":"CA Colton","year":"2014","unstructured":"Colton CA, Wilson JG, Everhart A, Wilcock DM, Puolivali J, Heikkinen T, Oksman J, Jaaskelainen O, Lehtimaki K, Laitinen T, et al. mNos2 deletion and human NOS2 replacement in Alzheimer disease models. J Neuropathol Exp Neurol. 2014;73:752\u201369.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2509_CR55","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3233\/JAD-2008-15404","volume":"15","author":"DM Wilcock","year":"2008","unstructured":"Wilcock DM, Colton CA. Anti-amyloid-beta immunotherapy in Alzheimer\u2019s disease: relevance of transgenic mouse studies to clinical trials. J Alzheimers Dis. 2008;15:555\u201369.","journal-title":"J Alzheimers Dis"},{"key":"2509_CR56","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1523\/JNEUROSCI.5066-07.2008","volume":"28","author":"DM Wilcock","year":"2008","unstructured":"Wilcock DM, Lewis MR, Van Nostrand WE, Davis J, Previti ML, Gharkholonarehe N, Vitek MP, Colton CA. Progression of amyloid pathology to Alzheimer\u2019s disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2. J Neurosci. 2008;28:1537\u201345.","journal-title":"J Neurosci"},{"key":"2509_CR57","doi-asserted-by":"publisher","first-page":"eabb5398","DOI":"10.1126\/sciadv.abb5398","volume":"7","author":"RA Neff","year":"2021","unstructured":"Neff RA, Wang M, Vatansever S, Guo L, Ming C, Wang Q, Wang E, Horgusluoglu-Moloch E, Song W-M, Li A. Molecular subtyping of Alzheimer\u2019s disease using RNA sequencing data reveals novel mechanisms and targets. Sci Adv. 2021;7:eabb5398.","journal-title":"Sci Adv"},{"key":"2509_CR58","doi-asserted-by":"publisher","first-page":"101888","DOI":"10.1016\/j.pneurobio.2020.101888","volume":"19","author":"C Netzahualcoyotzi","year":"2020","unstructured":"Netzahualcoyotzi C, Pellerin L. Neuronal and astroglial monocarboxylate transporters play key but distinct roles in hippocampus-dependent learning and memory formation. Prog Neurobiol. 2020;19:101888.","journal-title":"Prog Neurobiol"},{"key":"2509_CR59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.npep.2015.09.008","volume":"55","author":"F Reichmann","year":"2016","unstructured":"Reichmann F, Holzer P. Neuropeptide Y: A stressful review. Neuropeptides. 2016;55:99\u2013109.","journal-title":"Neuropeptides"},{"key":"2509_CR60","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.npep.2013.10.012","volume":"47","author":"E Borbely","year":"2013","unstructured":"Borbely E, Scheich B, Helyes Z. Neuropeptides in learning and memory. Neuropeptides. 2013;47:439\u201350.","journal-title":"Neuropeptides"},{"key":"2509_CR61","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/ana.410230202","volume":"23","author":"NW Kowall","year":"1988","unstructured":"Kowall NW, Beal MF. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer\u2019s disease. Ann Neurol. 1988;23:105\u201314.","journal-title":"Ann Neurol"},{"key":"2509_CR62","doi-asserted-by":"publisher","first-page":"9465","DOI":"10.3390\/ijms22179465","volume":"22","author":"Y Mao","year":"2021","unstructured":"Mao Y, Evans EE, Mishra V, Balch L, Eberhardt A, Zauderer M, Gold WA. Anti-semaphorin 4D rescues motor, cognitive, and respiratory phenotypes in a Rett syndrome mouse model. Int J Mol Sci. 2021;22:9465.","journal-title":"Int J Mol Sci"},{"key":"2509_CR63","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000367","volume":"4","author":"C LaGanke","year":"2017","unstructured":"LaGanke C, Samkoff L, Edwards K, Jung Henson L, Repovic P, Lynch S, Stone L, Mattson D, Galluzzi A, Fisher TL, et al. Safety\/tolerability of the anti-semaphorin 4D Antibody VX15\/2503 in a randomized phase 1 trial. Neurol Neuroimmunol Neuroinflamm. 2017;4: e367.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2509_CR64","unstructured":"Feigin A, Evans EE, Fisher TL, Leonard JE, Smith ES, Reader A, Mishra V, Manber R, Walters KA, Kowarski L, et al. Pepinemab antibody blockade of SEMA4D in early Huntington\u2019s Disease: the randomized, placebo-controlled, phase 2 SIGNAL trial. Nat Med. 2022."}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02509-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-022-02509-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02509-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T07:04:10Z","timestamp":1659769450000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-022-02509-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2509"],"URL":"https:\/\/doi.org\/10.1186\/s12974-022-02509-8","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,6]]},"assertion":[{"value":"4 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Live animal phase was conducted according to the following guidelines: Act on Use of Animals for Experimental Purposes (62\/2006), Finland; Ordinance number 36\/EEO\/2006 on experimental animals, Ministry of Agriculture and Forestry, Finland; Directive 2010\/63\/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purpose. All animal experiments are approved by the State Provincial Office of Southern Finland.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M. Zauderer, E.E. Evans, T.L. Fisher, V. Mishra, L. Balch, C. Mallow, A. Howell, E. Gersz, C. Reilly\u00a0and E.S. Smith are employees of Vaccinex, Inc. and own stock and\/or stock options in the company.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}